-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The continued popularity of China's biomedical venture capital is already a personal experience for every industry practitioner
As of June 2021, 5,794 pharmaceutical projects in China have received financing
As a large amount of capital flows into the medical and health track, the innovation system of the entire industry is activated
Behind the huge amount of funds are investment institutions that are eager for the medical and health industry
From the perspective of companies, it can be found that a batch of companies established in 2015 have had the most financing incidents
Secondly, among the projects that have completed financing over the years, the proportion of early-stage financing projects is getting lower and lower (shown in gray below)
Number of incubation projects of capital institutions over the years (Source: InvestGo)
The above is the venture capital trend of the entire medical and health track.
Since 2014, the overall financing of innovative drugs projects is 514.